IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million
IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), an OncoDNA company specializing in the genomics of cancer and rare genetic diseases, which performs interpretable genomic analyses for academic and private laboratories, announces today its unaudited sales for the first half of 2024.
Sales for the first half came to €2,540K, down 34% compared with the first half of 2024 on a like-for-like basis (excluding revenues from the SeqOIA platform), contrary to expectations of weak growth, comparable to that of 2024, as announced by the Company in its press release dated April 29, 2025, on its results for the 2024 financial year.
This decline is the result of reduced activity of over 40% on the Institut Pasteur's Mutualized Microbiology platform, linked to the drop in epidemiological sequencing, as well as to the decline in projects carried out on the Evry genomics platform, down by around 31%.
This decline is the result of delays in the start-up of two major projects, the first samples of which were received by the company in May, as well as a general slowdown in research projects for academic and hospital customers. The company believes that the second half of the year, with the acceleration of major projects (notably UMBRELLA) and improved funding conditions for public research, should enable the situation to improve from the third quarter onwards.
As of June 30 th, available cash, including the remainder on the loan granted to the parent company OncoDNA and repaid over the course of 2025, stood at €2.1m. The company used up €0.9m of cash in the first half of 2025, and at this rate may not have enough cash to ensure its financing for the next 12 months.
In this context, the company is exploring all strategic options to improve its situation and expects to reduce cash consumption in the second half of the year through the reduction of operating costs, the launch of services for several existing customers, external sources of financing, a resumption of customer research projects, as well as the expected upturn in customers' research budgets. Given the high level of uncertainty surrounding public research funding, the Company is not maintaining its revenue growth forecasts for 2025.
Bernard Courtieu, Chief Executive Officer of IntegraGen, comments: "The first half of the year has been extremely difficult, with both a sharp drop in academic and hospital research projects, linked to a reduction in public research financing, as well as a reduction in the budgets of several biotech companies in a sector affected by the general economic climate. Despite several successes such as the UMBRELLA project, whose operational launch was announced last month, IntegraGen needs to find new sources of funding to be able to ensure the continuity of its operations."
Investors are invited to carefully read section 4.2 of the 2024 Management Report on 'Principal risks and uncertainties facing the Company'.
Financial results for the first half of 2025 will be published in October.
ABOUT INTEGRAGEN
IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 40 employees and generated €8.5 million of turnover in 2024. Based in France, IntegraGen is part of the Belgian OncoDNA group present in Spain, UK, Germany and works with an international network of 35 distributors. The Group also provides biomarker testing and clinical interpretation tools to guide treatment and monitoring of late stage solid tumors and accelerate the development of new cancer drugs.
IntegraGen is listed on Euronext Growth in Paris (ISIN: FR0010908723 – Mnemo: ALINT – Eligible PEA- PME).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
13 minutes ago
- Business Insider
The head of McKinsey shares how he gets employees to tell him what they really think
What does the head of McKinsey & Company, one of the world's most prestigious consulting firms, say is essential to leading high-performing teams? Humor. "A little levity — a joke at your own expense, a lighthearted moment — can go a long way toward building trust, breaking down barriers, and democratizing the team room," Bob Sternfels, McKinsey's global managing partner and chair of the firm's board of directors, told Business Insider in a an email last month. Founded in 1926, McKinsey is approaching its 100th year in business. Sternfels, who was first elected by the firm's senior partners to lead it in 2021, said that while the firm might look and sound different than when it started, its mission and values have remained. He was reelected for a second three-year term in 2024 and heads the firm's 40,000 employees around the globe, a 10% reduction from 18 months prior. In addition to humor, one simple tool he uses to get employees to open up when he visits the firm's offices around the world is walking. "I like to invite small groups of colleagues on walks whenever I visit one of our offices — it's a great way to get moving and hear what's really on people's minds," he said. He also said he likes to join in on fun traditions that colleagues invite him to, like mochi-making in Tokyo, a hot wing challenge in Phoenix, and karaoke in Manila. Participating in these activities helps set a good tone before a town hall, he said, adding, "A little vulnerability on my part helps people open up." Sternfels is leading McKinsey as the consulting industry faces disruption brought on by AI, and the global economy faces major changes. A spokesperson for the firm said in May that AI was driving new levels of productivity and that it planned to hire thousands of new consultants this year. Sternfels said he's drilling down on three main issues in 2025. ("If you know anything about McKinsey consultants, you'll know we rarely have a single answer," he wrote.) They are: distinctive impact with clients, unrivaled employee development, and staying global as a firm. He said McKinsey was committed to professional development, noting Time magazine ranked it the "best company for future leaders" two years in a row. "We're also not shying away from continuing to build a diverse meritocracy. It doesn't matter who you are or where you're from — it only matters what you've got," he wrote. As for what he sees as the biggest growth areas looking forward, he said many CEOs are trying to navigate shifting trade policy and supply chain issues, and that "building a musical around geopolitics" is essential for this moment. Capturing the productivity gains of AI remains top of mind, and it's clear that just incorporating the technology won't be enough. "Companies will have to really rewire their organizations to fully benefit," he said of AI.
Business Wire
2 hours ago
- Business Wire
Almonty Industries Announces 1-for-1.5 Share Consolidation in Anticipation of Potential Nasdaq Listing
TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. (' Almonty ' or the ' Company ') (TSX: AII) (ASX: AII) (OTCQX: ALMTF) (Frankfurt: ALI), a leading global producer of tungsten concentrate, is pleased to announce that it has filed articles of amendment to consolidate its issued and outstanding common shares (' Shares ') on the basis of one (1) post-consolidation Share for every one and a half (1.5) pre-consolidation Shares (the ' Consolidation '). The Consolidation was approved by shareholders of the Company (' Shareholders ') at the annual general and special meeting of Shareholders held on April 30, 2025. The Company is implementing the Consolidation for the reasons disclosed in the management information circular dated March 21, 2025 (the ' Circular '), including to facilitate a potential Nasdaq listing. The Company expects that the Shares will commence trading on a post-Consolidation basis at the start of trading on July 7, 2025 on the Toronto Stock Exchange (the " TSX '), subject to receipt of necessary exchange approvals. Following the Consolidation, the new CUSIP number for the Shares will be 020398707 and the new ISIN number will be CA0203987072. Trading on the Australian Securities Exchange in CHESS Depositary Interests (' CDIs ') representing the Shares will commence on a deferred settlement basis at the start of trading on July 8, 2025. Trading in post-Consolidation CDIs on a normal settlement basis will commence at the start of trading on July 17, 2025. The Company expects to have approximately 195,860,844 Shares (including CDIs) outstanding following the Consolidation, subject to rounding for any fractional Shares. No fractional Shares will be issued in connection with the Consolidation. In the event that a Shareholder would otherwise be entitled to receive a fractional Share upon the occurrence of the Consolidation, such fraction will be rounded down to the nearest whole number. All stock options, warrants and other rights to purchase or otherwise acquire Shares shall be adjusted to reflect the Consolidation in accordance with the terms and conditions governing such convertible securities. Almonty's transfer agent, Computershare Investor Services Inc. (' Computershare '), will mail a letter of transmittal to registered Shareholders of the Company providing instructions on how to exchange existing Share certificates or direct registration system (DRS) statements. A sample letter of transmittal is also available on the Company's profile on SEDAR+. Non-registered Shareholders who hold their Shares through a bank, broker or other nominee and who have questions regarding how the Consolidation will be processed should contact their nominee. Until surrendered to Computershare, each Share certificate or other evidence representing pre-Consolidation Shares will be deemed for all purposes to represent the number of post-Consolidation Shares to which the registered Shareholder is entitled as a result of the Consolidation. New holding statements will be dispatched to holders of CDIs on a post-Consolidation basis between July 10, 2025 and July, 16 2025. The Consolidation remains subject to the final approval of the TSX. Additional details regarding the Consolidation can be found in the Circular, which is available under the Company's profile on SEDAR+ at About Almonty Almonty is a diversified and experienced global producer of tungsten concentrate in conflict-free regions. The Company is currently mining, processing and shipping tungsten concentrate from its Panasqueira Mine in Portugal. Its Sangdong Mine in Gangwon Province, South Korea is currently under construction. The Sangdong Mine was historically one of the largest tungsten mines in the world and one of the few long-life, high-grade tungsten deposits outside of China. Almonty also has a significant molybdenum resource on a separate property adjacent to the tungsten orebody at the Sangdong Mine. Additional development projects include the Valtreixal Project in northwestern Spain and Los Santos Mine in western Spain. Further information about Almonty's activities may be found at and under Almonty's profile at and Legal Notice The release, publication, or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published, or distributed should inform themselves about and observe such restrictions. Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward-Looking Information This news release contains 'forward-looking statements' and 'forward-looking information' within the meaning of applicable securities laws. All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as 'plan', 'development', 'growth', 'continued', 'intentions', 'expectations', 'emerging', 'evolving', 'strategy', 'opportunities', 'anticipated', 'trends', 'potential', 'outlook', 'ability', 'additional', 'on track', 'prospects', 'viability', 'estimated', 'reaches', 'enhancing', 'strengthen', 'target', 'believes', 'next steps' or variations of such words and phrases or statements that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking statements in this news release include, but are not limited to, statements concerning the Consolidation, the timing of trading of the Shares and CDIs on a post-Consolidation basis, the number of issued and outstanding Shares following completion of the Consolidation, the receipt of final approval for the Consolidation from the TSX, the delivery of letters of transmittal, the treatment of convertible securities in connection with the Consolidation, and a potential Nasdaq listing. Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate. Key assumptions upon which the Company's forward-looking information is based include, without limitation, the timely delivery of letters of transmittal and the ability of the Company to obtain final approval of the Consolidation from the TSX and to meet Nasdaq listing requirements. Forward-looking statements are also subject to risks and uncertainties facing the Company's business, including, without limitation, the impact of general economic conditions, industry conditions, and dependence on regulatory approvals. Any of these risks could have a material adverse effect on the Company's business, financial condition, results of operations and growth prospects. Readers should consider reviewing the detailed risk discussion in the Company's most recent Annual Information Form and the Amended Management Discussion and Analysis for the three months ended March 31, 2025 filed on SEDAR+, for a fuller understanding of the risks and uncertainties that affect the Company's business and operations. Although Almonty has attempted to identify important factors that could cause actual results, level of activity, performance or achievements to differ materially from those contained in forward-looking statements, there may be other factors that cause results, level of activity, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate and even if events or results described in the forward-looking statements are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, Almonty. Accordingly, readers should not place undue reliance on forward-looking statements and are cautioned that actual outcomes may vary. Investors are cautioned against attributing undue certainty to forward-looking statements. Almonty cautions that the foregoing list of material factors is not exhaustive. When relying on Almonty's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Almonty has also assumed that material factors will not cause any forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
Business Wire
3 hours ago
- Business Wire
Llama Group SA Announces a Capital Increase via a Private Placement of € 1.000.000
BRUSSELS--(BUSINESS WIRE)--Regulatory News: Llama Group SA (Euronext Growth Paris and Brussels: ALLAM), ('Llama Group' or the 'Company'), a digital music company and owner of the Winamp platform, today announces a capital increase for a total gross amount of € 1.000.000, subscribed by a limited number of investors (the 'Private Placement'). 'I would like to thank investors for their trust. This fundraising represents a key milestone for Llama Group and highlights the importance of our project in the music industry,' said Alexandre Saboundjian, CEO of Llama Group. 'Investors have recognised the potential of Winamp and the ambition driving our platform, designed to meet the needs of artists in a rapidly evolving music landscape. We remain more committed than ever to building an independent and innovative solution serving creators.' Use of Proceeds This transaction is part of Llama Group's ongoing strategic development. The funds raised will be primarily used to support the commercial launch of its new platform Winamp for Creators, by financing the initial phases of its go-to-market strategy — a central pillar of Llama Group's growth strategy. In parallel, the Company will continue to invest in the development of its two flagship products, Winamp for Creators and the Winamp Player, with the goal of enhancing features, improving user experience, and strengthening its positioning in the digital music market. The proceeds will also enable the Company to cover current operating expenses and meet its short-term financial commitments, in a context where its existing cash position requires supplementary funding alongside existing financing arrangements. Given current market conditions and the Company's stage of development, the private placement route was deemed the most appropriate and efficient financing solution at this time. Terms of the Private Placement The capital increase is carried out under the authorised capital framework, via the issuance of 1.666.668 new ordinary shares (the 'New Shares') at a subscription price of 0,60 € per share, representing a discount of approximately 21% compared to the Company's closing share price on the day prior to the announcement. The Private Placement is exclusively reserved for qualified investors — as defined under Rule 144A of the U.S. Securities Act of 1933 for subscribers located in the United States, and Article 2(e) of Regulation (EU) 2017/1129 for those based in the European Economic Area — with the statutory preferential subscription rights of existing shareholders being waived in the corporate interest. The New Shares: will be ordinary shares carry the same rights as the existing shares; will be fully paid-up, without nominal value, and issued in dematerialised form; will be entitled to dividends for the financial year starting 1 January 2025 if any; An application has been be made for admission to trading of the New Shares on Euronext Growth Brussels and Euronext Growth Paris as from their settlement and delivery. The capital increase for an amount of € 1.000.000 will raise the Company's share capital from € 29.859.118,30 to € 30.859.119,10. As the issue price is below the accounting par value, the entire subscribed amount will be allocated to the 'capital' account, without any share premium, so that all shares – both existing and new – will have the same accounting par value after completion. Subject to the closing of the capital increase having occurred, the Board of Directors will convene an Extraordinary General Meeting within fifteen (15) days following such closing. This meeting will take place no later than forty (40) days following the closing. 1 During such meeting, the shareholders will be asked to approve the issuance of 1.666.668 subscription rights ('Warrants') in favour of the investors who subscribed to the capital increase, without preferential subscription rights for existing shareholders. Each Warrant will entitle its holder to subscribe to one new ordinary share at an exercise price of 0,80 €, in accordance with the terms agreed between the Company and the investors. If a holder wishes to exercise its Warrants, it may do so only once for all Warrants owned by such holder, within five (5) years following the date on which the Warrants will have been effectively issued. The Company has committed to a 45-day standstill on the issuance of New Shares and transfer of shares of the Company, and the reference shareholder Maxximum SA has committed to a 60-day standstill on the transfer of shares of the Company, subject to customary and market-based exceptions. This structure enables Llama Group to quickly secure the resources needed while relying on professional investors able to support its long-term value creation strategy. Legal Basis of the Transaction In accordance with Article 7 of the Company's Articles of Association, the Board of Directors is authorised to increase the Company's share capital, in one or more tranches, until 4 March 2026, up to a maximum amount of € 22.841.742,87 (excluding any share premium), through the issuance of new shares, subscription rights or convertible bonds, via contributions in cash and/or in kind, with the ability to waive existing shareholders' preferential subscription rights. Immediately prior to this transaction, € 14.665.699,80 (excluding share premium) remained available under the authorised capital. Impact on Share Capital and Voting Rights Subject to the successful settlement and delivery of the New Shares, the Company's share capital will increase from € 29.859.118,30 to € 30.859.119,10, represented by 15.183.434 shares. The breakdown of the share capital and voting rights before and after the Private Placement is as follows: Before Private Placement Shareholders Shares Capital % Voting Rights Voting Rights % Maxximum SA 4,629,917 34.25% 8,615,636 49.23% Public 8,886,849 65.75% 8,886,849 50.77% Total 13,516,766 100.00% 17,502,485 100.00% Expand After Private Placement Shareholders Shares Capital % Voting Rights Voting Rights % Maxximum SA 4,629,917 30.49% 8,615,636 44.95% Public 10,553,517 69.51% 10,553,517 55.05% Total 15,183,434 100.00% 19,169,153 100.00% Expand Impact on Shareholders The stake of a shareholder holding 1% of the Company's share capital prior to the capital increase, and not participating in the Private Placement, would be diluted to approximately 0,89% following the issuance of 1.666.668 New Shares. In the event of full exercise of the 1.666.668 Warrants attached to the New Shares, this stake would be further reduced to approximately 0,80%. Financial Advisors Maxim Group LLC acted as placement agent and Allegra Finance acted as listing sponsor in the context of the Private Placement. The Private Placement is governed by agreements entered into between the Company and the placement. Risk Factors The public's attention is drawn to the risk factors relating to the Company and its business, as presented in the 2024 annual financial report published by the Company on April 1, 2025, available free of charge on its website ( The occurrence of some or all of these risks could have an adverse effect on the Company's business, financial position, results, development, or outlook. Prospectus Exemption The Private Placement, which is exclusively reserved for qualified investors, is not subject to the obligation to publish a prospectus or information note approved by the FSMA, in accordance with Article 10, § 3, 1° of the Law of 11 July 2018 on public offers of investment instruments and admissions of investment instruments to trading on regulated markets. The admission of the New Shares to trading on Euronext Growth Brussels and Paris is governed by the Royal Decree of 23 September 2018 on the publication of an information note in the event of a public offer or admission to trading on an MTF. In this respect, a verification was carried out and confirmed that the number of New Shares to be issued represents 12,3% of the number of Llama Group shares already admitted to trading on Euronext Growth over the past twelve months — i.e. below the 20% regulatory threshold. As a result, the transaction satisfies the exemption conditions under Article 3 of the Royal Decree, and no information note will be published. Next Meeting July 07, 2025 – Settlement and delivery of the Private Placement About Llama Group Llama Group is a pioneer and leader in the digital music industry. With extensive expertise across various sectors, the group owns the iconic Winamp platform, the Bridger copyright management company, and the Jamendo music licensing company. Llama Group's ambition is to build the future of the music industry through sustained investment in a range of innovative solutions and in the talent and skills of people who love music. The group stands by its brand values: empowerment, access, simplicity, and fairness. Winamp's vision is a world where a cutting-edge music platform connects artists and their fans like never before. Bridger's mission is to support songwriters and composers by providing a simple and innovative solution for collecting royalties. Jamendo enables independent artists to generate additional income through commercial licenses. Finally, Hotmix offers a bouquet of more than sixty thematic and free digital radio stations. Disclaimer This press release is for information purposes only. This press release does not constitute, and shall not be deemed to constitute, an offer to the public, an offer to subscribe or a solicitation of interest to the public with a view to a public offering of financial securities. The information set out above does not constitute and should not be considered as constituting a public offer, a subscription or purchase offer, or a solicitation of public interest in connection with a public offering of financial securities requiring the publication of a prospectus approved by the Financial Markets Authority (Autorité des Services et Marchés Financiers). The publication of this information in certain countries may constitute a breach of applicable legal provisions. This information must not be published, transmitted, released, or distributed, directly or indirectly, in or into the United States of America (including its territories and possessions), Canada, Australia, South Africa or Japan, or any other jurisdiction in violation of the relevant laws of such jurisdiction. The information made available above does not constitute an offer to sell or a solicitation of an offer to buy securities of the Company in the United States, Canada, Australia, South Africa, Japan, or in any other jurisdiction where such an offer or solicitation would be unlawful. The offering of the securities of the Company described in this press release is exclusively reserved to qualified investors, as provided in section « Terms of the Private Placement » of this press release. With respect to the member states of the European Economic Area, no action has been or will be taken to permit a public offering of the securities of the Company described in this press release that would require the publication of a prospectus in any such member state. Consequently, the securities of the Company described in this press release may not and will not be offered in any member state, except in accordance with the exemptions provided for in Article 1(4) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended (the 'Prospectus Regulation') or in other cases not requiring the publication of a prospectus by the Company under Article 3 of the Prospectus Regulation and/or applicable regulations in such member state. Without prejudice to any prohibitions in other jurisdictions, securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended (the 'U.S. Securities Act'), or an exemption from such registration. The securities of the Company described in this press release have not been and will not be registered under the U.S. Securities Act, and the Company does not intend to make any public offering of securities described in this press release in the United States.
